While amnestic-type MCI patients were specifically selected in 2 blood GSH studies [42, 43], most of the studies measuring blood GSH and all the studies measuring brain GSH either did not specify or included both amnestic and non-amnestic patients (Table 2)
SYSTEMIC SUPPORT Unlike localized treatments, oral BPC-157 can provide systemic benefits, supporting overall integrity as it circulates through the body
\n\n\n\n Cytokine Modulation and Anti-Inflammatory Research Findings \n\n\n\n Inflammation is central to injury and disease, and BPC-157 anti-inflammatory research has produced some of the compounds most consistently positive findings
Gee is Medical Director of InfusaLounge Integrative & Functional Medicine
We have more than 300 satisfied customers who are using our product around the country for Chelation (BCA), (ACT), High Dose Vitamin C Therapy, Nutrient Therapy, Ozone Therapy, Prolozon Therapy